Hui Ding

Serum miR-96-5p is a novel and non-invasive marker of acute myocardial infarction associated with coronary artery disease

Wen Chen, Xin Chen, Hui Ding, 2022, Bioengineered.

Comparison of clinical outcomes and postoperative recovery between two open heart surgeries: minimally invasive right subaxillary vertical thoracomy and traditional median sternotomy.

Juan Tan, Hui Ding, Chuan-xian Hu, 2014, Asian Pacific journal of tropical medicine.

Differentially expressed mRNAs and their upstream miR-491-5p in patients with coronary atherosclerosis as well as the function of miR-491-5p in vascular smooth muscle cells

Hui Ding, Chuan-xian Hu, Quanhua Pan, 2022, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

MicroRNA-564 inhibits the progression of non-small cell lung cancer via targeting plexin A4

Biao Gu, Liangpeng Li, Hui Ding, 2021, Experimental and therapeutic medicine.

Adverse events risk associated with anti-VEGFR agents in the treatment of advanced nonsmall-cell lung cancer

Biao Gu, Hui Ding, Junjie Lv, 2016, Medicine.

miR-98 inhibits cell proliferation and induces cell apoptosis by targeting MAPK6 in HUVECs

Su Huang, Hui Ding, Chuan-xian Hu, 2018, Experimental and therapeutic medicine.

Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease.

Hui Ding, Chuan-xian Hu, Jian-Kang Xu, 2019, Clinical laboratory.